Diagnostic Biomarkers in Alzheimer’s Disease
Description: Dr. Acosta describes the clinical diagnosis of Alzheimer’s disease (AD), discusses pathological changes and outlines the currently available AD biomarkers.
At the conclusion of this program, participants will be able to:
• Describe the clinical diagnosis of Alzheimer’s disease (AD)
• Discuss pathological changes in AD
• Outline currently available AD biomarkers
ASCLS P.A.C.E.® credits are available to laboratory professionals through January 31, 2019.